Free shipping over $81.00
For special pricing offers, free shipping may not be applicable.
  • 0
Shop Products Free shipping over $81.00
slider

Brands Fluoxetine

Fluoxetine Capsules, 20mg Strenght Antidepressant 1000 per Bottle

Product # : 72241-0008-11 Class : MDR Distributor : RELIANCE INC Category : Antidepressants 20 mg Strength Availability : Please contact customer service at info@RxReliance.com to check availability.
Non-Stock Item Information : Any reason may apply
  • This item ships directly from the manufacturer. Additional shipping charges may apply.
  • As a special order from the supplier, the approximate delivery time is 2-4 weeks.
  • For equipment such as beds, lifts, etc., a freight code is required. Please reach out to us to get the code.

$0.00

⚠️ License required to purchase this product.
Volume
Product Notices : This product may be non-returnable and/or require additional restocking fee.
Product Varient
Volume

Product Specifications

Product No. # 72241-0008-11
Manufacturer # 372241008115
Brand Fluoxetine
Manufacturer Modavar
Country of Origin India
Application Antidepressant
Volume 1000 Tablets Per Bottle
Container Type Bottle
Shipping Width 3.875
Shipping Height 6.5
Shipping Depth 3.875
Dimension UOM IC
Shipping Weight 1.425
Weight UOM LB
Active Ingredients Antidepressant
Container Type Bottle
Dosage Form Capsule
QTY_Per_Sell 1000
Strength 20 mg Strength
Volume 1000 Tablets Per Bottle
Simply_Medical_Category Antidepressants 20 mg Strength
Class MDR
Supply_Manager_Category Antidepressants 20 mg Strength
Supply_Manager_Hierarchy
Pharmaceuticals>Rx>Antidepressants>Antidepressant
California_Prop_65 No
Legend_Code Yes
Stock_Status NonStock
FSA_Eligible Yes
GTIN 372241008115
Ready to Sell Ready to sell
Pureplay CoT Restriction No
Features
  • INDICATIONS & USAGE:
  • Fluoxetine capsules are indicated for the treatment of:
  • Acute and maintenance treatment of Major Depressive Disorder.
  • Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD).
  • Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa.
  • Acute treatment of Panic Disorder, with or without agoraphobia.
  • Fluoxetine capsules and Olanzapine in Combination is indicated for the treatment of:
  • Acute treatment of depressive episodes associated with Bipolar I Disorder.
  • Treatment Resistant Depression (Major Depressive Disorder in patient, who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode).
  • Fluoxetine capsules monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder or the treatment of treatment resistant depression.
  • When using fluoxetine capsules and olanzapine in combination, also refer to the Clinical Studies section of the package insert for Symbyax®.